Newman, Edward M.

Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies

Siddiqi, T., Frankel, P., Beumer, J. H., Kiesel, B. F., Christner, S., Ruel, C., Song, J. Y., Chen, R., Kelly, K. R., Ailawadhi, S., et al. (2020) · Leukemia & Lymphoma

Lymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research

Cited by 30

Phase I study of TRC102 in combination with cisplatin and pemetrexed in patients with advanced solid tumors/Phase II study of TRC102 with pemetrexed in patients with mesothelioma refractory to pemetrexed and cisplatin or carboplatin.

Koczywas, M., Frankel, P. H., Riess, J. W., El-Khoueiry, A. B., Villaruz, L. C., Leong, S., Ruel, C., Synold, T. W., O'Connor, T., & Newman, E. M. (2020) · Journal of Clinical Oncology

Occupational and environmental lung diseasesCancer therapeutics and mechanisms

Cited by 2